Table 1.
Main patient characteristics
| Age (years) | median (range) | 66.5 (51-87) |
|---|---|---|
| Histology | Ductal/others | 55/11 |
| Grading (G) | ||
| 1 | 13 | |
| 2 | 43 | |
| 3 | 8 | |
| Chemotherapy | ||
| yes/no | 16/48 | |
| Hormonotherapy | yes/no | 58/6 |
| TAM | 6 | |
| A | 44 | |
| L | 8 | |
| Estrogen receptor | ||
| RE+ | 58 | |
| RE- | 6 | |
| Progesteron receptor | ||
| RP+ | 51 | |
| RP- | 13 | |
| tumor side | right/left | 26/38 |
| tumor diameter (mm) | median (range) | 12(2-30) |
| Quadrant | ||
| Upper | 58 | |
| Lower | 6 | |
| Tumor stage | ||
| Tis | 1 | |
| T1 | 53 | |
| T2 | 10 | |
| Nodal stage | N0/N1 | 60/4 |
| Follow-up (months) | median (25th - 75th) | 37(31 -39) |
Abbreviations:TAM = tamoxifen; A = anastrozole; L = letrozole